Trump's Marijuana Rescheduling Push Is Back in Focus. Is Tilray Stock Finally a Buy?
Yahoo Finance
The article discusses the renewed focus on President Trump's push to reschedule marijuana to Schedule III, a move that could significantly impact companies like Tilray Brands (NASDAQ: TLRY). While rescheduling wouldn't federally legalize recreational cannabis, it would ease research and expand medical marijuana opportunities, areas where Tilray already has a strong international presence. The author suggests that Tilray's improved financial standing makes it a more compelling investment now, eve
Read the full story
This is a short summary. The complete article is published by Yahoo Finance.
Headline and summary aggregated from public news feeds. For information only — not financial advice.